Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
48.80
-1.55 (-3.08%)
Dec 16, 2025, 4:00 PM EST
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$631,163
Profits / Employee
$207,532
Market Cap
216.60B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
| Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
| Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
| Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
| Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Zomedica | 152 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
Novo Nordisk News
- 11 hours ago - Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly - CNBC
- 18 hours ago - Novo Nordisk Loses Momentum As Eli Lilly Pulls Ahead In Weight-Loss Wars - Benzinga
- 18 hours ago - Novo Nordisk Loses Momentum As Eli Lilly Pulls Ahead In Weight-Loss Wars - Benzinga
- 1 day ago - CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval - Nasdaq
- 2 days ago - 2 Predictions for Novo Nordisk in 2026 - The Motley Fool
- 3 days ago - Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV - NDTV
- 4 days ago - European Regulator Backs Approval Of Novo Nordisk High-Dose Wegovy - Benzinga
- 4 days ago - NVO Down 42% Year to Date: Is This an Indication to Sell the Stock? - Nasdaq